Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to ...

Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...

In this expert perspective from Retina 2026, Ehsan Rahimy, MD, a retina specialist at Palo Alto Medical Foundation, discussed promising advancements in the treatment of retinal diseases.Rahimy said th ...

Researchers from the University of Toronto have found that older adults with diabetes who took semaglutide, a drug sold under ...

What if the medication you're taking for blood sugar control could also protect your vision? New research reveals a surprising connection between metformin and eye health—and doctors say vision ...

Ocugen has completed enrollment in liMeliGhT, its phase 3 clinical trial of OCU400 for the treatment of retinitis pigmentosa (RP). The company describes liMeliGhT as a 1-year clinical trial that will ...

Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets –– Topline data for ...

Cigarette smoke accelerates eye aging by causing epigenetic changes that block the eye's natural repair genes.

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

Prevent Blindness Ohio is declaring February as Age-related Macular Degeneration (AMD) and Low Vision Month in an effort to provide education and various expert-approved resources to the public and ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026. Allen C. Ho, MD, of ...